Literature DB >> 21868165

Trigeminocervical complex responses after lesioning dopaminergic A11 nucleus are modified by dopamine and serotonin mechanisms.

Annabelle R Charbit1, Simon Akerman, Peter J Goadsby.   

Abstract

Both serotonergic and dopaminergic receptor modulation can alter trigeminal nociceptive processing, and descending A11 dopaminergic projections can affect trigeminal nociceptive transmission. Here we aimed to test the interaction between dopamine D(2) and serotonin 5-HT(1B/1D) receptors and their individual and combined effects in order to better understand the relationship of the descending influences of these systems on nociceptive trigeminovascular afferents. Extracellular recordings were made in the rat trigeminocervical complex in response to electrical stimulation of the dura mater and mechanical noxious and innocuous stimulation of the ipsilateral ophthalmic dermatome. The A11 nucleus was lesioned, and following the resultant facilitation of neuronal firing, one of a selective 5-HT(1B/1D) receptor agonist (naratriptan), selective 5-HT(1B/1D) receptor antagonist (GR127935), a selective D(2)-like receptor agonist (quinpirole), and a selective D(1)-like receptor agonist (dihydrexidine), or a combination of the above, were administered. Both quinpirole and quinpirole with naratriptan inhibited firing in the trigeminocervical complex evoked by noxious stimuli, reducing it below prelesion baseline, while the response to innocuous stimuli was reduced back to baseline. Both naratriptan alone, and quinpirole combined with GR127935, inhibited firing in the trigeminocervical complex evoked by noxious stimuli, returning it to prelesion baseline, while the response to innocuous stimuli remained facilitated. Immunohistochemical staining demonstrated D(2)-receptor and 5-HT(1B/1D)-receptor colocalization in the trigeminocervical complex. The data suggest that the serotonergic and dopaminergic antinociceptive pathways act simultaneously on neurons in the trigeminocervical complex, and both amine systems need to be functioning for trigeminal sensitization to be reversed. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21868165     DOI: 10.1016/j.pain.2011.07.002

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  14 in total

1.  Spinal dopaminergic projections control the transition to pathological pain plasticity via a D1/D5-mediated mechanism.

Authors:  Ji-Young V Kim; Dipti V Tillu; Tammie L Quinn; Galo L Mejia; Adia Shy; Marina N K Asiedu; Elaine Murad; Alan P Schumann; Stacie K Totsch; Robert E Sorge; Patrick W Mantyh; Gregory Dussor; Theodore J Price
Journal:  J Neurosci       Date:  2015-04-22       Impact factor: 6.167

2.  A Critical Role for Dopamine D5 Receptors in Pain Chronicity in Male Mice.

Authors:  Salim Megat; Stephanie Shiers; Jamie K Moy; Paulino Barragan-Iglesias; Grishma Pradhan; Rebecca P Seal; Gregory Dussor; Theodore J Price
Journal:  J Neurosci       Date:  2017-11-22       Impact factor: 6.167

3.  Calbindin-Positive Neurons Co-express Functional Markers in a Location-Dependent Manner Within the A11 Region of the Rat Brain.

Authors:  Tsuyoshi Yamaguchi; Hidechika Ozawa; Shigeki Yamaguchi; Shinsuke Hamaguchi; Shuichi Ueda
Journal:  Neurochem Res       Date:  2021-01-13       Impact factor: 3.996

Review 4.  Serotonin, 5HT1 agonists, and migraine: new data, but old questions still not answered.

Authors:  Greg Dussor
Journal:  Curr Opin Support Palliat Care       Date:  2014-06       Impact factor: 2.302

5.  Brainstem reflexes are hyperactive in patients with drug-induced akathisia.

Authors:  Baris Metin; Sinem Zeynep Metin; Aysegul Gunduz; Burc Cagri Poyraz; Mine Ozmen; Gunes Kiziltan; Meral E Kiziltan
Journal:  Neurol Sci       Date:  2017-07-05       Impact factor: 3.307

Review 6.  Pathophysiology of Migraine: A Disorder of Sensory Processing.

Authors:  Peter J Goadsby; Philip R Holland; Margarida Martins-Oliveira; Jan Hoffmann; Christoph Schankin; Simon Akerman
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

Review 7.  Dopaminergic symptoms in migraine.

Authors:  Piero Barbanti; L Fofi; C Aurilia; G Egeo
Journal:  Neurol Sci       Date:  2013-05       Impact factor: 3.307

8.  Dopamine receptor D2, but not D1, mediates descending dopaminergic pathway-produced analgesic effect in a trigeminal neuropathic pain mouse model.

Authors:  Sufang Liu; Yuanyuan Tang; Hui Shu; Delton Tatum; Qian Bai; Joshua Crawford; Ying Xing; Mary Kay Lobo; Larry Bellinger; Phillip Kramer; Feng Tao
Journal:  Pain       Date:  2019-02       Impact factor: 7.926

9.  Severe Headache or Migraine History is Inversely Correlated With Dietary Sodium Intake: NHANES 1999-2004.

Authors:  Janice M Pogoda; Noah B Gross; Xianghong Arakaki; Alfred N Fonteh; Robert P Cowan; Michael G Harrington
Journal:  Headache       Date:  2016-03-26       Impact factor: 5.887

Review 10.  Roads Less Traveled: Sexual Dimorphism and Mast Cell Contributions to Migraine Pathology.

Authors:  Andrea I Loewendorf; Anna Matynia; Hakob Saribekyan; Noah Gross; Marie Csete; Mike Harrington
Journal:  Front Immunol       Date:  2016-04-19       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.